Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? - Test2 - elhamkhani - TriplyDB

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

http://www.wikidata.org/entity/Q24601893

about

Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease.Gene expression profiling and association with prion-related lesions in the medulla oblongata of symptomatic natural scrapie animals.GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus.Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2.Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.Gene and protein patterns of potential prion-related markers in the central nervous system of clinical and preclinical infected sheep Amyloid-β-neuropeptide interactions assessed by ion mobility-mass spectrometry.Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1 Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.Anticonvulsant neuropeptides as drug leads for neurological diseases.The neuropathological profile of mild cognitive impairment (MCI): a systematic review.Galanin receptors as a potential target for neurological disease.Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice.Galanin neurons in the intermediate nucleus (InM) of the human hypothalamus in relation to sex, age, and gender identity.Insights from the sequence similarity of Zika virus proteins with the Human nerve proteins

P2860

Q33643281-20C968BD-8ABD-4B93-870F-E3A5FC0B3A10 Q33908982-D8DEF218-8AD2-42B0-83DB-5A9E713DC38C Q33918266-39B25D17-4422-42ED-A90E-83715906A32C Q34093567-E9B5C7F5-79AF-4CA3-A847-38E26EB5300B Q35030514-14146C2D-7010-40FF-8C34-F2E043CB6CF7 Q35753039-015751D5-8E84-4EE1-BE0B-19BE51C43722 Q35838504-0B5F0010-2EF6-4090-983A-F85EFADD4843 Q36716041-AEFF45B1-EE96-43F9-BBBA-FE9920B2EA3F Q36879051-CFA3545F-1FFE-4263-96A7-0BDE112FEBB6 Q37169626-8F329BE7-E993-41AC-9236-1ECC91DAE771 Q37318152-9D40AE7A-3E9A-496B-B991-5915BF73CAD1 Q37845684-4F3D2598-512D-4D9A-8786-F61E05BDE51B Q37964897-B85F47E3-B332-432E-A98C-AAE140D962E5 Q38556483-13DB0B10-AE3C-4739-A47F-5F372600E7FD Q41886468-DCDE5AE6-8BD9-4199-9888-4296E2A8361A Q51458133-6749F12F-4F12-4A56-83BB-249C9578043B Q56361615-FA070802-662D-416E-A36A-058FBDAC9034

P2860

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

http://www.wikidata.org/entity/Q24601893

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@ast

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@en

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@nl

type

label

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@ast

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@en

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@nl

prefLabel

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@ast

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@en

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@nl

P1433

Q24601893-DA4BB0AD-2F88-4D2E-8388-78944586B24F

P1476

Q24601893-4C8F3075-6CBB-4D63-892F-C7F652B4ACAE

P2093

Q24601893-0D067B0B-59AF-4687-A781-023F589C5792

Q24601893-3375C008-E5CD-4EFD-A04B-3CF8A6D6E19B

Q24601893-CA6EEE42-880A-4CB2-B609-A475AAE3BCE9

P2860

Q24601893-0460DB0A-1AC8-4CC9-BA99-DE99C0E3AC1C

Q24601893-050E7AE1-F73C-46D5-9AD8-E6F725E62C7D

Q24601893-05DD5552-AA73-4A20-9C65-1F0F35DCB7F8

Q24601893-06A52457-F77F-4EBC-9BF8-824DA2F4A1E5

Q24601893-0B1FC4B8-E831-4E9B-96D0-FC6369FAFF48

Q24601893-0CB4F12A-986D-4CCE-804C-1B77D79C2C8B

Q24601893-0CDED162-B421-4A64-9BD9-C357C650B2CA

Q24601893-0D615B84-9A62-4488-A52F-CE78872299A6

Q24601893-102B933B-E18F-452F-A184-FD4DD1B1D200

Q24601893-10AD7EF5-C30F-485B-BD70-B45231D576AB

P2888

Q24601893-14595FF4-7784-421F-8044-AEE6339D0125

P304

Q24601893-62840DC2-AFAE-423E-8C01-9964A2478322

P31

Q24601893-206222DE-D795-4220-8429-D056C157807A

P356

Q24601893-69E68D62-817D-4CB7-A179-05D378BE61A5

P407

Q24601893-7BE153EE-EC74-4E41-ACFD-63E96D05668E

P433

Q24601893-0CE36FEE-C8FE-4DFA-9B4F-1840432F1E1E

P478

Q24601893-7F02E1F9-4C5D-4A01-A602-22FE256FF8B8

P577

Q24601893-77CACC14-88CC-4CF5-9C79-DE6A5F3DA39E

P5875

Q24601893-BE396E63-BA52-4682-A7BD-9863C024D9F7

P6179

Q24601893-BD20B834-86A1-4016-9330-B428B25C0601

P698

Q24601893-F572C9D3-7E7E-48EC-AA89-09458543343C

P921

Q24601893-3055E5DB-1FDC-4A41-A243-B3B71384F41E

Q24601893-7E648C5E-30B3-4EEF-BD61-8BDF15840AB6

P932

Q24601893-E29A17A9-23A0-42A1-A684-E97BAE696793

P356

S00018-008-8159-2

P1433

Cellular and Molecular Life Sciences

P1476

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

@en

P2093

E J Mufson

http://www.w3.org/2001/XMLSchema#string

S E Counts

http://www.w3.org/2001/XMLSchema#string

S E Perez

http://www.w3.org/2001/XMLSchema#string

P2860

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests

Galanin receptor subtypes

Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: The effects of subtype-selective agonists and the role of G-protein-mediated signaling

Galanin in Alzheimer disease

Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice

Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons

Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover

Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes

P2888

s00018-008-8159-2

P304

1842-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-008-8159-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5348868

http://www.w3.org/2001/XMLSchema#string

P6179

1019090204

http://www.w3.org/2001/XMLSchema#string

P698

18500641

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2911017

http://www.w3.org/2001/XMLSchema#string